BSPHO, the Belgian Society of Paediatric Haemato-Oncology
BSPHO is a Brussels-based non-profit professional society, founded in 1996, that coordinates paediatric haemato-oncology care, clinical trials, and training across Belgium's eight recognised treatment centres, serving approximately 500 children diagnosed with cancer annually.
- Company typePrivate
- Founded1996
- HeadquartersBrussels, Belgium
- Headcount1–10
- GTM typeB2B
- OfferingServices
What BSPHO, the Belgian Society of Paediatric Haemato-Oncology does
BSPHO (Belgian Society of Paediatric Haemato-Oncology) is a non-profit professional medical society founded in 1996 and headquartered in Brussels, Belgium. It unites the eight recognised Belgian paediatric haemato-oncology centres — CHU de Liège, CHC MontLegia, Cliniques Universitaires Saint-Luc, HUDERF-HUB, UZ Antwerpen, UZ Gent, and UZ Leuven — and their interdisciplinary professionals (paediatric oncologists, surgeons, radiotherapists, pharmacists, psychologists, study coordinators, nurses, and rehabilitation staff) to coordinate care, share expertise, and improve outcomes for children and adolescents with cancer in Belgium, a population of roughly 500 new diagnoses annually representing less than 1% of all Belgian cancer cases.
The society operates a public multilingual website (bspho.be), a members-only professional portal (pro.bspho.be), and a dedicated training platform (training.bspho.be) that delivers courses for medical and paramedical staff alongside patient and family educational materials. Its core services include national coordination of clinical studies, facilitation of access to international paediatric oncology trials, scholarship programmes for training, and advocacy for improved reimbursement and centralisation of paediatric cancer care. BSPHO also represents Belgium in European networks, including SIOPe (whose membership BSPHO members automatically receive), PanCare (survivorship), and the European Reference Networks for rare diseases.
BSPHO is funded almost exclusively through donations and grants rather than commercial revenue. Membership for qualified physicians and fellows is free. Major donors and partners include Foundation Against Cancer, Kick Cancer, Kinderkankerfonds, King Baudouin Foundation, Kiwanis International, Kom Op Tegen Kanker, the Belgian National Lottery (continuous support since 2021), and Run for Hope. The organisation is authorised to issue tax-deductible donation receipts in Belgium for contributions of EUR 40 or more, with up to 30% tax deductibility.
BSPHO, the Belgian Society of Paediatric Haemato-Oncology firmographics
Firmographics- Name
- BSPHO, the Belgian Society of Paediatric Haemato-Oncology
- Legal name
- Belgian Society of Paediatric Haematology Oncology
- Website
- https://bspho.be
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BSPHO is a Brussels-based non-profit professional society, founded in 1996, that coordinates paediatric haemato-oncology care, clinical trials, and training across Belgium's eight recognised treatment centres, serving approximately 500 children diagnosed with cancer annually.
- Ownership category
- akta.pro rank
BSPHO, the Belgian Society of Paediatric Haemato-Oncology industry classification
Industry- Product category
- Paediatric Oncology Medical Society Coordination
- NAICS
- Other Individual and Family Services (62419)
- SIC
- Services-Misc Health & Allied Services, Nec (8090)
- akta.pro industry
- Pediatric Hematology & OncologyClinical Trial Monitoring Support (On-site/Remote)Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)
Keywords
Where BSPHO, the Belgian Society of Paediatric Haemato-Oncology is headquartered
LocationHeadquarters
- HQ city
- Brussels
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
BSPHO, the Belgian Society of Paediatric Haemato-Oncology business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Donations and Fundraising: BSPHO raises funds through its 'To Cure and Beyond' fundraising campaign. Donations support clinical trials setup, scholarships for training, educational materials for patients and families, and scientific collaboration between Belgian treatment centres. The organization is authorized to give tax exemptions for donations (minimum 40 EUR for tax deductibility up to 30%).
Distribution channels1 record
Marketing channels5 records
BSPHO, the Belgian Society of Paediatric Haemato-Oncology product offering
Product offeringCore offering
BSPHO is a non-profit professional medical society that coordinates Belgium's 8 recognised paediatric haemato-oncology centres, facilitates access to international clinical trials, delivers professional training programmes, and provides long-term follow-up support for childhood cancer survivors. Its services include coordination of interdisciplinary working groups, scholarships for medical training, patient and family educational resources, and advocacy for improved reimbursement and centralisation of paediatric cancer care in Belgium.
Product overview
BSPHO is a professional society, not a product company. It does not offer commercial software products. BSPHO provides professional services including: coordination of Belgian pediatric haemato-oncology centers, clinical trial coordination for childhood cancer, professional training programs via training.bspho.be, a members-only professional area at pro.bspho.be, patient and family educational resources, advocacy for pediatric cancer care, and scholarship programs for training in pediatric haemato-oncology.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Coordination
Quantifiable outcome
- Improved survival rates for childhood cancer through participation in international clinical trials
- +1 more outcomes
Companies that use BSPHO, the Belgian Society of Paediatric Haemato-Oncology
Customer profileSegments1 record
Ideal customer profiles2 records
BSPHO, the Belgian Society of Paediatric Haemato-Oncology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BSPHO, the Belgian Society of Paediatric Haemato-Oncology partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and major.
- SIOPe (International Society of Paediatric Oncology Europe)coreBSPHO members automatically join SIOPe. BSPHO collects yearly membership fees for both organisations. SIOPe is the European professional society for paediatric oncology, representing the field at European level.
- PanCaremajorBSPHO participates in PanCare, a European network studying survivorship issues and developing guidelines for long-term follow-up of childhood cancer survivors.
- European Reference Networks (ERN)majorBSPHO participates in European Reference Networks, which facilitate collaboration on rare diseases including paediatric cancers across EU member states.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
BSPHO, the Belgian Society of Paediatric Haemato-Oncology competitors and assessment
Company assessmentDirect peers
- GPOH (Gesellschaft für Pädiatrische Onkologie und Hämatologie): German professional society for paediatric oncology and haematology, coordinating German treatment centres and clinical trial groups. Direct peer in mandate and structure, with substantially larger scale and a frequent PanCare/ERN collaborator.
- DCOG (Dutch Children's Oncology Group): Dutch national coordinating group for paediatric oncology, running the same functions as BSPHO (clinical trials, protocols, late effects research) for Dutch centres. Directly comparable in scale and remit, and a frequent cross-border collaborator through PanCare and SIOPe.
- ASPHO (American Society of Pediatric Hematology/Oncology): US-based professional society for paediatric haematology-oncology physicians, providing research, education, training, and advocacy — the closest functional analogue in the US market and a key international counterpart to BSPHO via SIOP.
- CCLG (Children's Cancer and Leukaemia Group): UK-based professional group coordinating paediatric cancer research and treatment across British centres. Structurally identical to BSPHO — a clinical trials group and professional society — but larger in scale and a benchmark BSPHO often interacts with via SIOPe/ERN.
- SIOP (International Society of Paediatric Oncology): Global parent body for paediatric oncology professionals, of which SIOPe is the European regional arm. Directly comparable as a professional membership society organising paediatric oncology research, education, and advocacy worldwide.
- SIOPe (International Society of Paediatric Oncology Europe): European umbrella society for paediatric oncology; BSPHO members automatically join SIOPe and BSPHO collects yearly membership fees on its behalf. SIOPe is the closest functional peer — a professional society coordinating paediatric oncologists across multiple European countries.
- AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica): Italian national association for paediatric haematology-oncology coordinating treatment centres across Italy. Directly comparable in mission (clinical trials, centre coordination, training) and operates within the same SIOPe ecosystem.
Regional players
- SFCE (Société Française des Cancers de l'Enfant et de l'Adolescent): French national society for paediatric and adolescent cancers, coordinating clinical trials and treatment protocols across French centres — a near-twin to BSPHO in terms of mission, structure, and centre-coordination role in the neighbouring francophone market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
BSPHO, the Belgian Society of Paediatric Haemato-Oncology social profiles
Digital presenceBSPHO, the Belgian Society of Paediatric Haemato-Oncology financial estimates
Financial estimateRevenue estimate
Valuation estimate
BSPHO, the Belgian Society of Paediatric Haemato-Oncology leadership team
Management profileNumber of profiles
Profiles7 records
BSPHO, the Belgian Society of Paediatric Haemato-Oncology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BSPHO, the Belgian Society of Paediatric Haemato-Oncology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BSPHO, the Belgian Society of Paediatric Haemato-Oncology
What does BSPHO, the Belgian Society of Paediatric Haemato-Oncology do?
BSPHO is a non-profit professional medical society that coordinates Belgium's 8 recognised paediatric haemato-oncology centres, facilitates access to international clinical trials, delivers professional training programmes, and provides long-term follow-up support for childhood cancer survivors. Its services include coordination of interdisciplinary working groups, scholarships for medical training, patient and family educational resources, and advocacy for improved reimbursement and centralisation of paediatric cancer care in Belgium.
Is BSPHO, the Belgian Society of Paediatric Haemato-Oncology a public or private company?
BSPHO, the Belgian Society of Paediatric Haemato-Oncology is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was BSPHO, the Belgian Society of Paediatric Haemato-Oncology founded?
BSPHO, the Belgian Society of Paediatric Haemato-Oncology was founded in 1996. It employs 1 to 10 people.
Where is BSPHO, the Belgian Society of Paediatric Haemato-Oncology based?
BSPHO, the Belgian Society of Paediatric Haemato-Oncology is headquartered in Brussels, Belgium, in the Europe region.
How does BSPHO, the Belgian Society of Paediatric Haemato-Oncology make money?
One revenue line is on record: donations and Fundraising.
Who are BSPHO, the Belgian Society of Paediatric Haemato-Oncology's main competitors?
Direct peers on record are GPOH (Gesellschaft für Pädiatrische Onkologie und Hämatologie), DCOG (Dutch Children's Oncology Group), ASPHO (American Society of Pediatric Hematology/Oncology), CCLG (Children's Cancer and Leukaemia Group), SIOP (International Society of Paediatric Oncology), SIOPe (International Society of Paediatric Oncology Europe) and AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica). SFCE (Société Française des Cancers de l'Enfant et de l'Adolescent) is listed as a regional player.
Does BSPHO, the Belgian Society of Paediatric Haemato-Oncology have an API?
No public API is recorded for BSPHO, the Belgian Society of Paediatric Haemato-Oncology.
What industry is BSPHO, the Belgian Society of Paediatric Haemato-Oncology in?
BSPHO, the Belgian Society of Paediatric Haemato-Oncology's product category is Paediatric Oncology Medical Society Coordination. Its primary akta.pro industry code is HLAKAFAE, Pediatric Hematology & Oncology, with a secondary code of HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote). Its NAICS code is 62419 and its SIC code is 8090.